326 related articles for article (PubMed ID: 18638711)
1. Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients.
He Y; Lu A; Zha Y; Tsang I
Complement Ther Med; 2008 Aug; 16(4):206-11. PubMed ID: 18638711
[TBL] [Abstract][Full Text] [Related]
2. Correlations between symptoms as assessed in traditional chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine.
He Y; Lu A; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Lu C
J Clin Rheumatol; 2007 Dec; 13(6):317-21. PubMed ID: 18176139
[TBL] [Abstract][Full Text] [Related]
3. Association between tongue appearance in Traditional Chinese Medicine and effective response in treatment of rheumatoid arthritis.
Jiang M; Zha Q; Lu C; He Y; Lu A
Complement Ther Med; 2011 Jun; 19(3):115-21. PubMed ID: 21641515
[TBL] [Abstract][Full Text] [Related]
4. [Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine].
He YT; Zha QL; Yu JP; Tan Y; Lu C; Lu AP
Zhong Xi Yi Jie He Xue Bao; 2008 Jan; 6(1):32-6. PubMed ID: 18184543
[TBL] [Abstract][Full Text] [Related]
5. [Stage-based treatment of gouty arthritis by combination therapy of traditional Chinese and Western medicines: a randomized controlled trial].
Wang YF; Li BH; Zhang M; Xu WB; Zhou R; Zhou M
Zhong Xi Yi Jie He Xue Bao; 2008 Jun; 6(6):576-80. PubMed ID: 18559233
[TBL] [Abstract][Full Text] [Related]
6. [Predictive role of diagnostic information in treatment efficacy of rheumatoid arthritis based on neural network model analysis].
Zha QL; He YT; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH; Lin SQ; Lü C; Lü AP
Zhong Xi Yi Jie He Xue Bao; 2007 Jan; 5(1):32-8. PubMed ID: 17214933
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on symptomatic factors of rheumatoid arthritis and its correlation with therapeutic efficacy].
He YT; Zha QL; Yan XP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1077-81. PubMed ID: 16398426
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
10. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
13. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
14. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
15. [Correlations of clinical symptoms and treatment efficacy in patients with rheumatoid arthritis treated with Chinese herbal drugs or Western medicine].
Lü AP; He YT; Zha QL; Yan XP; Su L; Song YJ; Zeng SP; Liu W; Feng XH; Qian X; Zhu WH
Zhong Xi Yi Jie He Xue Bao; 2005 Nov; 3(6):432-7. PubMed ID: 16282050
[TBL] [Abstract][Full Text] [Related]
16. A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis.
Furst DE; Fleischmann R; Kopp E; Schiff M; Edwards C; Solinger A; Macri M;
J Rheumatol; 2005 Dec; 32(12):2303-10. PubMed ID: 16331754
[TBL] [Abstract][Full Text] [Related]
17. [The role of the conventional drugs in the treatment of rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241
[TBL] [Abstract][Full Text] [Related]
18. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis.
He Y; Lu A; Lu C; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Tsang I
Am J Chin Med; 2008; 36(4):675-83. PubMed ID: 18711765
[TBL] [Abstract][Full Text] [Related]
19. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP
Arthritis Rheum; 2009 Feb; 60(2):335-44. PubMed ID: 19180516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
